Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

People with alopecia areata have a higher risk of heart disease.

Some medicinal plants can help heal wounds and may lead to new treatments.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Mutations in the KRT85 gene cause hair and nail problems.

Transdermal drug delivery systems are effective and promising for future use.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Alopecia treatment should use a modern, combined approach to effectively address hair loss.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

An integrated approach involving dermatologists, psychiatrists, and psychologists is crucial for managing skin disorders linked to psychological factors.

MicroRNAs may help diagnose and treat hair loss disorders.

Fat tissue under the skin affects hair growth and aging; reducing its inflammation may help treat hair loss.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Aging skin causes inflammation that affects the whole body.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.